NO930032L - Doseringsform for administrering av et medikament for aa frembringe circadian terapi - Google Patents

Doseringsform for administrering av et medikament for aa frembringe circadian terapi

Info

Publication number
NO930032L
NO930032L NO93930032A NO930032A NO930032L NO 930032 L NO930032 L NO 930032L NO 93930032 A NO93930032 A NO 93930032A NO 930032 A NO930032 A NO 930032A NO 930032 L NO930032 L NO 930032L
Authority
NO
Norway
Prior art keywords
administrating
medicine
making
dosage form
circadian
Prior art date
Application number
NO93930032A
Other languages
English (en)
Other versions
NO930032D0 (no
Inventor
Patrick S-L Wong
Frank Jao
Felix Theeuwes
Andrew Lam
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO930032D0 publication Critical patent/NO930032D0/no
Publication of NO930032L publication Critical patent/NO930032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Det omtales en osmoseanordning (10) som omfatter en første og andre innretning som samvirker for å frembringe et medikamentfritt tidsintervall forut for avgivelsen av, et medikament (15) fra innersiden av anordningen (10). Den første innretning senker passasjen av fluid gjennom veggen (12) og inn i anordningen (10), mens den andre innretning i anordningen forsinker avgivelsen av medikament (16) fra anordningen (10).
NO93930032A 1990-07-12 1993-01-07 Doseringsform for administrering av et medikament for aa frembringe circadian terapi NO930032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55181990A 1990-07-12 1990-07-12
PCT/US1991/004810 WO1992000729A1 (en) 1990-07-12 1991-07-08 Dosage form for administering a drug to effect circadian therapy

Publications (2)

Publication Number Publication Date
NO930032D0 NO930032D0 (no) 1993-01-07
NO930032L true NO930032L (no) 1993-01-15

Family

ID=24202810

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93930032A NO930032L (no) 1990-07-12 1993-01-07 Doseringsform for administrering av et medikament for aa frembringe circadian terapi

Country Status (16)

Country Link
EP (1) EP0538335B1 (no)
JP (1) JP2948906B2 (no)
AT (1) ATE116845T1 (no)
AU (1) AU652169B2 (no)
CA (1) CA2046448C (no)
DE (1) DE69106709T2 (no)
DK (1) DK0538335T3 (no)
ES (1) ES2069897T3 (no)
FI (1) FI930097L (no)
IE (1) IE62720B1 (no)
MX (1) MX9100118A (no)
NO (1) NO930032L (no)
NZ (1) NZ238867A (no)
PT (1) PT98252B (no)
WO (1) WO1992000729A1 (no)
ZA (1) ZA915274B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
UA74141C2 (uk) 1998-12-09 2005-11-15 Дж.Д. Сірл Енд Ко. Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
WO2004012705A1 (en) * 2002-07-31 2004-02-12 Phafag Ag A pharmaceutical formulation and its use in the treatment of inner ear diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4847093A (en) * 1986-06-19 1989-07-11 Alza Corporation Dosage form with means for governing rate of gas formation
AU621182B2 (en) * 1989-01-30 1992-03-05 Alza Corporation Dosage form for administering calcium antagonist
FI900470A7 (fi) * 1989-01-31 1990-08-01 Ipa Int Pharma Agentur Gmbh Aktiiviaineita säädetysti vapauttava systeemi ja menetelmä sen valmistamiseksi

Also Published As

Publication number Publication date
AU652169B2 (en) 1994-08-18
CA2046448C (en) 2006-05-02
JPH05508844A (ja) 1993-12-09
ATE116845T1 (de) 1995-01-15
NZ238867A (en) 1993-08-26
DK0538335T3 (da) 1995-06-19
FI930097A0 (fi) 1993-01-11
WO1992000729A1 (en) 1992-01-23
MX9100118A (es) 1992-09-01
ZA915274B (en) 1992-04-29
DE69106709T2 (de) 1995-05-11
IE62720B1 (en) 1995-02-22
DE69106709D1 (de) 1995-02-23
EP0538335A1 (en) 1993-04-28
PT98252B (pt) 1998-12-31
FI930097A7 (fi) 1993-01-11
FI930097L (fi) 1993-01-11
IE912373A1 (en) 1992-01-15
NO930032D0 (no) 1993-01-07
ES2069897T3 (es) 1995-05-16
AU8204791A (en) 1992-02-04
CA2046448A1 (en) 1992-01-13
EP0538335B1 (en) 1995-01-11
JP2948906B2 (ja) 1999-09-13
PT98252A (pt) 1992-05-29

Similar Documents

Publication Publication Date Title
NO923590L (no) Doseringsform for avgivelse av medikament til tarmen
van Der Hulst et al. Treatment of Helicobacter pylori infection: a review of the world literature
NO306377B1 (no) Doseform for avgivelse av et medikament
CY1112260T1 (el) Σκευασματα υδροκωδονης ελεγχομενης απελευθερωσης
DE69940674D1 (de) Orale verabreichung von adenosin analogen
SE8703034D0 (sv) Oralt terapeutiskt system med systemisk verkan
IT1270594B (it) Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
NO20055880L (no) Memantin orale doseringsformer
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
DK239782A (da) Kapsler indeholdende det aktive princip i et allergen og fremgangsmaade til fremstilling deraf
ATE100708T1 (de) Unbeschichtete pharmazeutische reaktionstablette.
ATE99927T1 (de) Pharmazeutische formulierungen.
BR9709838A (pt) Regime de administração que fornece um perfil de plasma no sangue de um inibidor de h+,k+-atpase composição farmacêutica oral uso da mesma e de inibidor h+,k+-atpase e processos para melhorar a inibição de secreção de ácido gástrico e o efeito terapêutico no tratamento de perturbações gastrintestinais e para receber um perfil estendido de plasma de um inibidor de h+,k+-atpase
NO894616L (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
NO923397L (no) Avgivelsesanordning
DE69516671D1 (de) Verbindungen mit analgetischem und lokalanesthetischem effekt
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
MY100780A (en) Azumolene dosage form.
NO930032D0 (no) Doseringsform for administrering av et medikament for aa frembringe circadian terapi
Jacknowitz et al. Nitrofurantoin polyneuropathy: report of two cases
DE69531166D1 (de) Arzneistoff zur erleichterung der durch immunsuppressiva verursachten nebenwirkungen
SU906521A1 (ru) Способ предупреждени беременности